Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
about
Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis.Biomarker profile in breast carcinomas presenting with bone metastasis.Src inhibitors in the treatment of metastatic bone disease: rationale and clinical dataThe science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumorsExpression of sarcosine metabolism-related proteins according to metastatic site in breast cancer.Site-specific metabolic phenotypes in metastatic breast cancer.Phosphorylation of serine 68 of Twist1 by MAPKs stabilizes Twist1 protein and promotes breast cancer cell invasivenessExpression of reactive oxygen species-related proteins in metastatic breast cancer is dependent on the metastatic site.Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical PracticeExpression of Lipid Metabolism-Related Proteins in Metastatic Breast CancerThe ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis.Expression of Yes-associated protein (YAP) in metastatic breast cancer.Expression of cancer-associated fibroblast related proteins in metastatic breast cancer: an immunohistochemical analysis.Clinical Response of Metastatic Breast Cancer to Multi-targeted Therapeutic Approach: A Single Case Report.Bone metastasis risk factors in breast cancer.SRC-1 and Twist1 expression positively correlates with a poor prognosis in human breast cancer.The influence of breast cancer subtype on bone metastases development and survival in women with metastatic breast cancer.TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis.Differential Site-Based Expression of Pentose Phosphate Pathway-Related Proteins among Breast Cancer Metastases.A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer.The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer.Pathological features and clinical outcomes of breast cancer according to levels of oestrogen receptor expression.How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment.
P2860
Q33563273-6BBAAF65-7EE3-43F0-8F8E-D029DAE778DCQ33604642-0D617584-48CC-4A40-A485-180055D2FD9CQ34182834-217C677C-E4FF-40D4-B484-0D8E1139CA14Q34617864-89158904-4768-4B5B-8AF9-213CB98F5D5DQ34733271-B61D63F7-A5BE-4BB9-A494-C7879528D5E5Q34788659-1A5E3D54-8F0A-4038-97A5-DB0F67CD1CEFQ35022183-2EEE10DD-7C65-4EB6-9A24-66F54352CA53Q35038622-D35D9212-6EEF-4A69-AE49-C3895361B5FEQ35667196-DB4C2AB1-1360-463C-8ABC-BA3CE159BC54Q35763076-978B21A4-F582-4B34-978D-6EB0682488FFQ36228169-7BC73B42-482C-4BB0-A8F4-91ED51BD5939Q36261738-B2DA237E-9715-48CA-A067-A5B24E1B4506Q36433471-F247D07E-CF41-45B4-9DE5-5F716DEBAA8DQ37129903-EA1FD868-124B-4FF4-8E34-6F93ED528365Q37629662-6C5C2A02-E3C0-4F57-BD81-1D92FE729C43Q37692730-C0DBA15E-040C-4298-BFB0-9A13695CFBB2Q39297208-824797AD-21FE-4126-B890-999C9D36A705Q41598833-D059D92D-C217-46F3-A246-5CD62FFD5EE1Q42321189-6120A1EE-F1D0-482D-93AD-FE1FB309AB79Q42944293-1719B873-32DB-4B3B-A6F7-11BCA39E7BA6Q46031627-07A898FF-3C95-4E60-9026-51E302D8AD94Q46398978-D2ACC452-152C-4B74-A560-97D7F2B10D3DQ55316580-8CAB6029-0767-4E57-B8F3-1774E23FC0FD
P2860
Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Bone metastasis is strongly as ...... or-negative breast carcinomas.
@en
Bone metastasis is strongly as ...... or-negative breast carcinomas.
@nl
type
label
Bone metastasis is strongly as ...... or-negative breast carcinomas.
@en
Bone metastasis is strongly as ...... or-negative breast carcinomas.
@nl
prefLabel
Bone metastasis is strongly as ...... or-negative breast carcinomas.
@en
Bone metastasis is strongly as ...... or-negative breast carcinomas.
@nl
P2093
P1433
P1476
Bone metastasis is strongly as ...... or-negative breast carcinomas.
@en
P2093
David Hicks
Jianmin Wang
Patricia Bourne
P304
P356
10.1016/J.HUMPATH.2008.05.010
P407
P577
2008-08-19T00:00:00Z